Literature DB >> 309913

Evidence that cytotoxic T cells are part of the host's response to influenza pneumonia.

F A Ennis, M A Wells, G M Butchko, P Albrecht.   

Abstract

Cytotoxic T cells were detected in the cervical lymph nodes, lungs, spleen, and peripheral blood of mice with influenza. Lymphocytes decreased in the peripheral circulation and increased in the lung during the period of acute inflammation and pneumonia. Peak cytotoxic T-cell activity was present at the time of marked pulmonary infiltration, and it decreased with resolution of the pneumonia. The cytotoxic T cells in the lung were shown to be H-2 restricted and specific for the hemagglutinin of the infecting virus. The results indicate that hemagglutinin specific cytotoxic T cells are (a) induced during influenza infection; (b) they circulate in the blood; (c) they are present in greatest number; and (d) they have their peak cytotoxic effect when pneumonia is most marked. We interpret the results to indicate that specific cytotoxic T cells in the infected target organ are part of the immunological and pathological response to virus infection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 309913      PMCID: PMC2185051          DOI: 10.1084/jem.148.5.1241

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses.

Authors:  H J Zweerink; S A Courtneidge; J J Skehel; M J Crumpton; B A Askonas
Journal:  Nature       Date:  1977-05-26       Impact factor: 49.962

2.  Cytotoxic T cells specific for influenza virus-infected target cells.

Authors:  K L Yap; G L Ada
Journal:  Immunology       Date:  1977-02       Impact factor: 7.397

3.  Immunologic recognition of influenza virus-infected cells. I. Generation of a virus-strain specific and a cross-reactive subpopulation of cytotoxic T cells in the response to type A influenza viruses of different subtypes.

Authors:  T J Braciale
Journal:  Cell Immunol       Date:  1977-10       Impact factor: 4.868

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. I. Stimulation by phytohaemagglutinin.

Authors:  D Roos; J A Loos
Journal:  Biochim Biophys Acta       Date:  1970-12-29

Review 6.  T cell response to viral and bacterial infection.

Authors:  R V Blanden
Journal:  Transplant Rev       Date:  1974

7.  Enhanced immunogenicity of chemically-coated syngeneic tumor cells.

Authors:  W J Martin; J R Wunderlich; F Fletcher; J K Inman
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

8.  Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens.

Authors:  F A Ennis; W J Martin; M W Verbonitz; G M Butchko
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

9.  Hemagglutinin-specific cytotoxic T-cell response during influenza infection.

Authors:  F A Ennis; W J Martin; M W Verbonitz
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

10.  Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses.

Authors:  R B Effros; P C Doherty; W Gerhard; J Bennink
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

View more
  16 in total

1.  The role of cell surface expression of influenza virus neuraminidase in induction of human lymphocyte apoptosis.

Authors:  Joan E Nichols; Jean A Niles; Elisa H Fleming; Norbert J Roberts
Journal:  Virology       Date:  2019-06-10       Impact factor: 3.616

2.  Flow cytometric analysis of pulmonary lymphocytes from mice infected with respiratory syncytial virus.

Authors:  P J Openshaw
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

3.  Killer T cell responses to influenza A during a drift period: studies in mice.

Authors:  D Armerding; H Rossiter; E Liehl
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

4.  Cytomegalovirus-specific cytotoxicity mediated by non-T lymphocytes from peripheral blood of normal volunteers.

Authors:  N Kirmani; R K Ginn; K K Mittal; J F Manischewitz; G V Quinnan
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

5.  Neurological involvement in mice after infection with a cold-adapted herpes simplex type 2 virus.

Authors:  D D Huang; G D Abrams; H F Maassab
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

6.  Antivirus antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection.

Authors:  J E Manischewitz; G V Quinnan
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

Review 7.  Some newly recognized aspects of resistance against and recovery from influenza.

Authors:  A Ennis
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

8.  Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice.

Authors:  A Bot; A Reichlin; H Isobe; S Bot; J Schulman; W M Yokoyama; C A Bona
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

9.  Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection.

Authors:  P A Offit; S L Cunningham; K I Dudzik
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Rescue of anti-influenza A virus cytotoxic T-lymphocyte responses in chemotherapy-suppressed mice.

Authors:  V J Merluzzi; K Welte; R H Mertelsmann; L Souza; T Boone; K Last-Barney
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.